Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation

OBJECTIVE: The intrarenal renin-angiotensin system (RAS) is activated in chronic kidney disease (CKD) patients and is not suppressed at night in CKD patients showing nocturnal hypertension, contributing to renal damage. Furthermore, changes in RAS inhibitor administration from morning to evening, na...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Taro, Ohashi, Naro, Isobe, Shinsuke, Ishigaki, Sayaka, Matsuyama, Takashi, Sato, Taichi, Fujikura, Tomoyuki, Kato, Akihiko, Miyajima, Hiroaki, Yasuda, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578605/
https://www.ncbi.nlm.nih.gov/pubmed/32938851
http://dx.doi.org/10.2169/internalmedicine.4243-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578605/
https://www.ncbi.nlm.nih.gov/pubmed/32938851
http://dx.doi.org/10.2169/internalmedicine.4243-19

Ejemplares similares